SAN FRANCISCO (MarketWatch) -- Hi-Tech Pharmacal Co. shares fell 29% to $14.05 Thursday morning after the Amityville, N.Y.-based company reported a first-quarter net loss of $959,000, or 8 cents a ...

SAN MATEO, Calif.--(BUSINESS WIRE)--Model N (NYSE: MODN), the leader in revenue optimization and compliance, today announced its Spring 2023 product release for life sciences and high-tech customers.

PETERSBURG – The city’s pharmaceutical industry received a major shot in the arm Monday after the U.S. Economic Development Administration tagged it with a “Tech Hub” designation that will allow it to ...

Share prices for Amityville-based drugmaker Hi-Tech Pharmacal have been surging through the trading day on news of a $1.9 billion buyout within the pharmaceutical industry. Hi-Tech's stock is up over ...

Co announces the FDA granted tentative approval to the co's Abbreviated New Drug Application for Calcipotriene topical solution, 0.005%. Hi-Tech's Calcipotriene topical solution is the generic ...

Amityville-based Hi-Tech Pharmacal Co. Inc.'s share price fell sharply by mid-day Tuesday, by more than 15 percent, after news that a Mumbai, India, firm had received approval for a competing generic ...

Overview: aTyr Pharma, Inc. is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammation by leveraging tRNA synthetase biology, with a market cap of $480.13 ...

Co announces it entered into a settlement and release agreement regarding the patent infringement suit brought by MedPointe Pharmaceuticals related to Hi-Tech's generic version of Tussi-12 DS, covered ...